Chromocell Therapeutics Corporation Stock
Equities
CHRO
US1711261057
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | -1.69% | +16.00% | 0.00% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 10.23M |
---|---|---|---|---|---|
Net income 2022 | -2M | Net income 2023 | -7M | EV / Sales 2022 * | - |
Net cash position 2022 * | - | Net cash position 2023 * | - | EV / Sales 2023 * | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 * |
-
| Employees | 6 |
Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 27.22% |
Latest transcript on Chromocell Therapeutics Corporation
1 day | -1.69% | ||
1 week | +16.00% | ||
Current month | -2.79% | ||
1 month | -27.50% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 10.23M | |
-1.65% | 103B | |
+6.75% | 101B | |
+5.71% | 23.07B | |
-12.60% | 22.23B | |
-9.70% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- CHRO Stock